Market Tracker

12/02 5:16pm ET

Enzon Pharmaceuticals Inc (OTCQX US:ENZN)

0.44
Delayed Data
As of Dec 02
 -0.0125 / -2.76%
Today’s Change
0.35
Today|||52-Week Range
0.75
-35.53%
Year-to-Date
Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals
Dec 02 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close0.45
Today’s open0.46
Day’s range0.42 - 0.47
Volume832,967
Average volume (3 months)144,682
Market cap$20.0M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-24.62%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-44.00%
P/E ratio1.2
Price/Sales1.73
Price/Book1.11

Competitors

No competitors data available.

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$17.5M
Annual profit (last year)$21.6M
Net profit margin123.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Secretary
Andrew D. Rackear
Principal Financial &
Accounting Officer
Richard L. Feinstein
Corporate headquarters
Cranford, New Jersey

Forecasts